{"example_id": "1242-00", "context": "A mixture of itaconic acid (1.3 g, 10 mmol) and p-chlorobenzylamine (1.28 ml, 11 mmol) was stirred at 120 \u00b0C for 4 hours. Thereafter, the solvent.", "anaphor": "the solvent", "gold_antecedents": ["p-chlorobenzylamine (1.28 ml, 11 mmol)"], "preceding_anaphors": []}
{"example_id": "1242-01", "context": "A mixture of itaconic acid (1.3 g, 10 mmol) and p-chlorobenzylamine (1.28 ml, 11 mmol) was stirred at 120 \u00b0C for 4 hours. Thereafter, the solvent was evaporated off under reduced pressure, and the obtained crystals.", "anaphor": "the obtained crystals", "gold_antecedents": ["A mixture of itaconic acid (1.3 g, 10 mmol) and p-chlorobenzylamine (1.28 ml, 11 mmol)"], "preceding_anaphors": ["the solvent"]}
{"example_id": "1242-02", "context": "A mixture of itaconic acid (1.3 g, 10 mmol) and p-chlorobenzylamine (1.28 ml, 11 mmol) was stirred at 120 \u00b0C for 4 hours. Thereafter, the solvent was evaporated off under reduced pressure, and the obtained crystals were washed with a mixed solution of acetic acid and hexane (1:9) to obtain the title compound (2.3 g, yield 92%).", "anaphor": "the title compound (2.3 g, yield 92%)", "gold_antecedents": ["A mixture of itaconic acid (1.3 g, 10 mmol) and p-chlorobenzylamine (1.28 ml, 11 mmol)", "a mixed solution of acetic acid and hexane (1:9)"], "preceding_anaphors": ["the solvent", "the obtained crystals"]}
{"example_id": "0775-01", "context": "Similarly to example 1.8, starting from 66 mg (0.5 mmol) of 3-fluorophenylboronic acid and 150 mg (0.3 mmol) of 5-bromo-3-methyl-1-{2-oxo-2-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione (prepared as described in example 2.5), 30 mg (20%) of 5-(3-fluorophenyl)-3-methyl-1-{2-oxo-2-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione is obtained in the form of a white solid.", "anaphor": "a white solid", "gold_antecedents": ["66 mg (0.5 mmol) of 3-fluorophenylboronic acid", "150 mg (0.3 mmol) of 5-bromo-3-methyl-1-{2-oxo-2-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione"], "preceding_anaphors": ["30 mg (20%) of 5-(3-fluorophenyl)-3-methyl-1-{2-oxo-2-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione"]}
{"example_id": "0200-00", "context": "1-Fluoro-3-iodopropane (40.9 \u03bcL, 0.39 mmol) was added to a solution of N-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenyl)azetidin-3-amine (169 mg, 0.39 mmol) and DIPEA (203 \u03bcL, 1.16 mmol) in NMP (1.7 mL) at room temperature. After 18 hours, the reaction.", "anaphor": "the reaction", "gold_antecedents": ["1-Fluoro-3-iodopropane (40.9 \u03bcL, 0.39 mmol)", "a solution of N-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenyl)azetidin-3-amine (169 mg, 0.39 mmol) and DIPEA (203 \u03bcL, 1.16 mmol) in NMP (1.7 mL)"], "preceding_anaphors": []}
{"example_id": "0200-01", "context": "1-Fluoro-3-iodopropane (40.9 \u03bcL, 0.39 mmol) was added to a solution of N-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenyl)azetidin-3-amine (169 mg, 0.39 mmol) and DIPEA (203 \u03bcL, 1.16 mmol) in NMP (1.7 mL) at room temperature. After 18 hours, the reaction was concentrated under reduced pressure. The resulting residue.", "anaphor": "The resulting residue", "gold_antecedents": ["1-Fluoro-3-iodopropane (40.9 \u03bcL, 0.39 mmol)", "a solution of N-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenyl)azetidin-3-amine (169 mg, 0.39 mmol) and DIPEA (203 \u03bcL, 1.16 mmol) in NMP (1.7 mL)"], "preceding_anaphors": ["the reaction"]}
{"example_id": "0200-02", "context": "1-Fluoro-3-iodopropane (40.9 \u03bcL, 0.39 mmol) was added to a solution of N-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenyl)azetidin-3-amine (169 mg, 0.39 mmol) and DIPEA (203 \u03bcL, 1.16 mmol) in NMP (1.7 mL) at room temperature. After 18 hours, the reaction was concentrated under reduced pressure. The resulting residue was purified by reverse phase flash chromatography (C18), eluting with decreasingly polar mixtures of water (containing 0.2% ammonium hydroxide) and MeCN as eluents. Product fractions.", "anaphor": "Product fractions", "gold_antecedents": ["1-Fluoro-3-iodopropane (40.9 \u03bcL, 0.39 mmol)", "a solution of N-(4-((6S,8R)-7-((1-fluorocyclopropyl)methyl)-8-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)-3-methoxyphenyl)azetidin-3-amine (169 mg, 0.39 mmol) and DIPEA (203 \u03bcL, 1.16 mmol) in NMP (1.7 mL)", "C18", "eluents"], "preceding_anaphors": ["the reaction", "The resulting residue"]}
{"example_id": "0876-00", "context": "The same procedure as in Reaction Scheme 1-13 of Synthesis Example 1 was carried out, with the exception of using Intermediate 6-h and Intermediate 7-c instead of Intermediate 1-h and Intermediate 1-l, respectively, to afford Compound 44 (4.1 g): yield 36.3%.", "anaphor": "Compound 44 (4.1 g): yield 36.3%", "gold_antecedents": ["Intermediate 6-h", "Intermediate 7-c"], "preceding_anaphors": []}
